News & Updates

Events | News
Luiz Belardinelli, Chief Medical Officer will be presenting at the Chief Medical Officer Summit 360˚ on Oct 14, 2021
Read More
News
Mick Hurrey, VP of Product Development was a speaker at the American Drug Delivery & Formulation Summit 2021
Read More
News
Carlos Schuler, COO & CTO speaking at the 2nd Annual Inhalation and Respiratory Drug Conference on Sept 10, 2021.
Read More
News | Press Releases
InCarda Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for InRhythm™ for Treatment of Atrial Fibrillation
Read More
News
InCarda CEO Grace Colón Elected to the Board of the Biotechnology Innovation Organization (BIO)
Read More
News | Press Releases
InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team
Read More
News
InCarda CEO Grace Colón Elected to the Board of the MIT Corporation
Read More
Events
Grace Colón Participates on Panel Hosted by Women in Bio (WIB)
Read More
Events | News
Grace Colón Participates in virtual workshop “Innovation in Drug Research and Development for Prevalent Chronic Diseases”
Read More
News
InCarda Therapeutics featured in Men’s Health
Read More
News | Press Releases
InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation
Read More
Events | News
InCarda’s CEO Grace Colon participated in a panel discussion at Biotech Showcase 2021 on January 11, 2021
Read More

We’re proud to share what’s new.

Sign up to be the first to learn about new developments.

We respect your email privacy

Clinical Announcement
InCarda Therapeutics Recruiting for Phase 2 Clinical Trial in PAF
Read More